Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.11 CHF | -1.00% | -2.96% | +7.35% |
27/05 | Novartis: positive phase III results in C3G | CF |
27/05 | Novartis: presented results for kidney disease | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.35% | 21TCr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 33TCr | |
+0.24% | 28TCr | |
+13.47% | 24TCr | |
-6.42% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr | |
-1.31% | 12TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Credit Suisse remains Neutral